Top

Neurocritical Care

Published in:

01-08-2009 | Practical Pearl

Continuous Renal Replacement Therapy for Refractory Intracranial Hypertension

Authors: Jeffrey J. Fletcher, Karen Bergman, Eric C. Feucht, Paul Blostein

Published in: Neurocritical Care | Issue 1/2009

Abstract

Introduction

Little is known about the effects of hemodialysis on the injured brain, however; concern exists over the use of intermittent hemodialysis in patients with acute brain injury (ABI) due to its hemodynamic effects and increased intracranial pressure (ICP) associated with therapy. Continuous renal replacement therapy (CRRT) has become the preferred method of renal support in these patients though there is limited data to support its safety. Furthermore, exacerbations of cerebral edema have been reported. CRRT is an option for the treatment of hypervolemia and in theory may improve intracranial compliance. We report the case of a poly-trauma patient with severe traumatic brain injury (TBI) in which CRRT was implemented solely for refractory intracranial hypertension.

Methods

A 28-year-old male was involved in a high-speed motor vehicle collision suffering a severe TBI and polytrauma. He required significant volume resuscitation. Intensive care unit course was complicated by shock, acute respiratory distress syndrome, ventilator associated pneumonia, and development of intracranial hypertension (IH). Data were collected by retrospective chart review.

Results

Continuous hemofiltration was initiated for IH refractory to medical therapy. Within hours of initiation increase, ICP improved and normalized. Hemofiltration was safely discontinued after 48 h. Modified Rankin Score was 2 at 90 days.

Conclusion

Though unproven, CRRT may be beneficial in patients with IH due to gentle removal of fluid, solutes, and inflammatory cytokines. Given the limited data on safety of CRRT in patients with ABI, we encourage further reports.

Davenport A. Renal replacement therapy in the patient with acute brain injury. Am J Kidney Dis. 2001;31(3):457–66.CrossRef

Davenport A. Renal replacement therapy for the patient with acute traumatic brain injury and severe acute kidney injury. Contrib Nephrol. 2007;156:333–9. doi:10.1159/000102124.PubMedCrossRef

Silver SM, Sterns RH, Halperin ML. Brain swelling after dialysis: old urea or new osmoles? Am J Kidney Dis. 1996;28(1):1–13. doi:10.1016/S0272-6386(96)90124-9.PubMedCrossRef

Davenport A, Will EJ, Davison AM. Early changes in intracranial pressure during haemofiltration treatment in patients with grade 4 hepatic encephalopathy and acute oliguric renal failure. Nephrol Dial Transplant. 1990;5(3):192–8.PubMed

Davenport A, Will EJ, Davison AM. Continuous vs. intermittent forms of haemofiltration and/or dialysis in the management of acute renal failure in patients with defective cerebral autoregulation at risk of cerebral oedema. Contrib Nephrol. 1991;93:225–33.PubMed

Bertrand YM, Hermant A, Mahieu P, Roeb J. Intracranial pressure changes in patients with head trauma during hemodialysis. Intensive Care Med. 1983;9:321–3. doi:10.1007/BF01692550.PubMedCrossRef

Bellomo R, Tipping P, Boyce N. Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med. 1993;21:522–6. doi:10.1097/00003246-199304000-00011.PubMedCrossRef

Schetz M. Evidence-based analysis of the use of hemo-filtration in sepsis and MODS. Curr Opin Intens Care. 1997;3:434–41. doi:10.1097/00075198-199712000-00006.CrossRef

Shenkin HA, Bezier HS, Bouzarth WF. Restricted fluid intake: rational management of the neurosurgical patient. J Neurosurg. 1976;45:432–6.PubMedCrossRef

10.

Shenkin HA, Bouzarth WF, Tatsumi T. The analysis of body water compartments in postoperative craniotomy patients: part 1. The effects of major brain surgery alone: part 2. The effects of mannitol administered preoperatively. J Neurosurg. 1967;28:417.

11.

Ramming S, Schackford S, Zhuang J. The relationship of fluid balance and sodium administration to cerebral edema formation and intracranial pressure in a porcine model of brain injury. J Trauma. 1994;37(5):705–13. doi:10.1097/00005373-199411000-00003.PubMedCrossRef

12.

Clifton GL, Miller ER, Choi SC. Fluid thresholds and outcome from severe brain injury. Crit Care Med. 2002;30(4):739–45. doi:10.1097/00003246-200204000-00003.PubMedCrossRef

13.

Schmoker JD, Schackford SR, Wald SL, et al. An analysis of the relationship between fluid and sodium administration and intracranial pressure after head injury. J Trauma. 1992;33:476–81. doi:10.1097/00005373-199209000-00024.PubMedCrossRef

14.

Silver S. Cerebral edema after rapid dialysis is not caused by an increase in brain organic osmolytes. J Am Soc Nephrol. 1995;6:1600–6.PubMed

15.

Trachtman H, Futterweit S, Tonidandel W, Gullans S. The role of organic osmolytes in the cerebral cell volume regulatory response to acute and chronic renal failure. J Am Soc Nephrol. 1993;3:1913–9.PubMed

16.

Arieff AI, Massry SG, Barrientos A, Kleeman CR. Brain water and electrolyte metabolism in uremia: effects of slow and rapid hemodialysis. Kidney Int. 1973;4:177–87. doi:10.1038/ki.1973.100.PubMedCrossRef

17.

Arieff A, Guisade R, Massry S, Lazarowitz V. Central nervous system pH in uremia and the effects of hemodialysis. J Clin Invest. 1976;58:306–11. doi:10.1172/JCI108473.PubMedCrossRef

18.

Galons JP, Trouard T, Gmitro AF, Lien YH. Hemodialysis increases apparent diffusion coefficient of brain water in nephrectomized rats measured by isotropic diffusion-weighted magnetic reasonance imaging. J Clin Invest. 1996;98(3):750–5. doi:10.1172/JCI118847.PubMedCrossRef

19.

Goldsmith DA, Forni LG, Hilton PJ. Bicarbonate therapy and intracellular acidosis. Clin Sci. 1997;93:593–8.PubMed

20.

Davenport A. Is there a role for continuous renal replacement therapies in patients with liver and renal failure? Kidney Int. 1999;56:62–6. doi:10.1046/j.1523-1755.56.s.72.3.x.CrossRef

21.

Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet. 2000;356:26–30. doi:10.1016/S0140-6736(00)02430-2.PubMedCrossRef

22.

Schiffl H, Lang S, Fischer R. Daily haemodialysis and the outcome of acute renal failure. N Engl J Med. 2002;346:305–10. doi:10.1056/NEJMoa010877.PubMedCrossRef

23.

Palevsky PM, Zhang JH, O’Connor TZ, et al. VA/NIH Acute Renal Failure Trial Network. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008;359(1):7–20. doi:10.1056/NEJMoa0802639.PubMedCrossRef

24.

Ghahramani N, Shadrou S, Hollenbeak C. A systematic review of continuous renal replacement therapy and intermittent haemodialysis in management of patients with acute renal failure. Nephrology. 2008;13:570–8.PubMedCrossRef

25.

Rabindranath K, Adams J, Macleod AM, Muirhead N. Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev 2007; Available from: www.cochrane.org.

26.

Davenport A, Will EJ, Losowski MS, Swindells S. Continuous arteriovenous hemofiltration in patients with hepatic encephalopathy and renal failure. Br Med J (Clin Res Ed). 1987;295:1098.CrossRef

27.

Caruso DM, Giancarlo V, Karl AG, et al. Continuous hemodialysis for the management of acute renal failure in the presence of cerebellar hemorrhage. J Neurosurg. 1998;89:649–52.PubMedCrossRef

28.

Davenport A, Will EJ, Losowsky MS. Rebound surges of intracranial pressure as a consequence of forced ultrafiltration used to control intracranial pressure in patients with severe hepatorenal failure. Am J Kidney Dis. 1989;14(6):516–9.PubMed

Title: Continuous Renal Replacement Therapy for Refractory Intracranial Hypertension
Authors: Jeffrey J. Fletcher
Karen Bergman
Eric C. Feucht
Paul Blostein
Publication date: 01-08-2009
Publisher: Humana Press Inc
Published in: Neurocritical Care / Issue 1/2009
Print ISSN: 1541-6933
Electronic ISSN: 1556-0961
DOI: https://doi.org/10.1007/s12028-009-9197-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Continuous Renal Replacement Therapy for Refractory Intracranial Hypertension

Abstract

Introduction

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Introduction

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2009

Clinical Differences Between Angiographically Negative, Diffuse Subarachnoid Hemorrhage and Perimesencephalic Subarachnoid Hemorrhage

Intra-arterial Air Thrombogenesis after Cerebral Air Embolism Complicating Lower Extremity Sclerotherapy

Induced Normothermia Attenuates Intracranial Hypertension and Reduces Fever Burden after Severe Traumatic Brain Injury

A Life Worth Living: Seven Years after Craniectomy

A Second Chance

Raymond Adams: A Life of Mind and Muscle by Robert Laureno